black_swan_luke_mcdermott

Black Swan Analysis appoints Luke McDermott

pharmafile | February 28, 2011 | Appointment | Sales and Marketing |  Black Swan Analysis, Luke McDermott, appointment, sales and marketing 

Maidenhead, UK-based Black Swan Analysis has expanded its analysis and forecasting team with the appointment of Luke McDermott.

He joins the company as a business analyst and brings with him a strong scientific and business background following the completion of an MSc from the University of Warwick.

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content